T1	Participants 238 254	cancer patients.
T2	Participants 361 371	population
T3	Participants 633 640	patient
T4	Participants 783 830	Twenty-two head and neck cancer patients from U
T5	Participants 1159 1171	Participants
T6	Participants 1301 1324	Patients in both groups
T7	Participants 1661 1667	number
T8	Participants 1706 1714	Patients
T9	Participants 1872 1880	patients
T10	Participants 2074 2103	Patients in the control group
T11	Participants 2164 2174	test group
T12	Participants 2318 2329	IFRS groups
T13	Participants 2474 2484	IFRS group
T14	Participants 2761 2774	control group
T15	Participants 2783 2794	study group
T16	Participants 3488 3495	patient
